Melodiol Global Health (Melodiol Global Health) Receivables Turnover : 3.34 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Melodiol Global Health Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Melodiol Global Health's Revenue for the six months ended in Dec. 2023 was $7.98 Mil. Melodiol Global Health's average Accounts Receivable for the six months ended in Dec. 2023 was $2.39 Mil. Hence, Melodiol Global Health's Receivables Turnover for the six months ended in Dec. 2023 was 3.34.

Melodiol Global Health Receivables Turnover Historical Data

The historical data trend for Melodiol Global Health's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health Receivables Turnover Chart

Melodiol Global Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

3.57

5.12

28.51

7.33

8.70

Melodiol Global Health Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Receivables Turnover	Get a 7-Day Free Trial										2.30	3.48	2.14	2.09	3.34

Competitive Comparison of Melodiol Global Health's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Melodiol Global Health's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's Receivables Turnover falls into.

Melodiol Global Health Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Melodiol Global Health's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	12.665	/ (	(1.308	+	1.602)	/	2 )
=	12.665	/	1.455
=	8.70

Melodiol Global Health's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

	Receivables Turnover (Q: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2023 )	/ (	(Accounts Receivable (Q: Jun. 2023 )	+	Accounts Receivable (Q: Dec. 2023 ))	/	count )
=	7.983	/ (	(3.182	+	1.602)	/	2 )
=	7.983	/	2.392
=	3.34

Melodiol Global Health (OTCPK:COPHD) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Melodiol Global Health Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Melodiol Global Health (Melodiol Global Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (OTCPK:COPHD) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

1X80:Germany ME1:Australia

Address

145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009

Website

https://www.cresopharma.com

Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (Melodiol Global Health) Headlines

From GuruFocus

Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision

By PRNewswire PRNewswire • 02-08-2023

Sierra Sage Herbs Acquired By Creso Pharma

By PRNewswire PRNewswire • 02-07-2022